The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 11, 2013, Pages 2242-2258

  Schaaij Visser, Tieneke B M ^a,b   De Wit, Meike ^a   Lam, Siu W ^a   Jiménez, Connie R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cancer secretome; Clinical application; Proteomics; Secreted protein biomarker; Tumor microenvironment; Unconventional secretion

Indexed keywords

CANCER SECRETOME; CATHEPSIN D; COLLAGEN TYPE 4; EPITHELIAL CELL ADHESION MOLECULE; FIBROBLAST GROWTH FACTOR 9; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; MASPIN; MATRIX METALLOPROTEINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANGIOGENESIS; ARTICLE; ASCITES FLUID; BREAST CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; FECES; HUMAN; LARGE CELL CARCINOMA; LIQUID CHROMATOGRAPHY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MASS SPECTROMETRY; NIPPLE ASPIRATION; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE; TUMOR CELL LINE; TUMOR LOCALIZATION;

EID: 84884813444     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.01.029     Document Type: Review

References (113)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
3. M.P. Coleman, M. Quaresma, F. Berrino, J.M. Lutz, A.R. De, R. Capocaccia, P. Baili, B. Rachet, G. Gatta, T. Hakulinen, A. Micheli, M. Sant, H.K. Weir, J.M. Elwood, H. Tsukuma, S. Koifman, E.S. GA, S. Francisci, M. Santaquilani, A. Verdecchia, H.H. Storm, and J.L. Young Cancer survival in five continents: a worldwide population-based study (CONCORD) Lancet Oncol. 9 2008 730 756
4. R. Siegel, C. Desantis, K. Virgo, K. Stein, A. Mariotto, T. Smith, D. Cooper, T. Gansler, C. Lerro, S. Fedewa, C. Lin, C. Leach, R.S. Cannady, H. Cho, S. Scoppa, M. Hachey, R. Kirch, A. Jemal, and E. Ward Cancer treatment and survivorship statistics, 2012 CA Cancer J. Clin. 62 2012 220 241
5. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
6. J.A. Ludwig, and J.N. Weinstein Biomarkers in cancer staging, prognosis and treatment selection Nat. Rev. Cancer 5 2005 845 856 (Pubitemid 41746029)
7. N. Rifai, M.A. Gillette, and S.A. Carr Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 24 2006 971 983 (Pubitemid 44215392)
8. M.P. Coleman, D. Forman, H. Bryant, J. Butler, B. Rachet, C. Maringe, U. Nur, E. Tracey, M. Coory, J. Hatcher, C.E. McGahan, D. Turner, L. Marrett, M.L. Gjerstorff, T.B. Johannesen, J. Adolfsson, M. Lambe, G. Lawrence, D. Meechan, E.J. Morris, R. Middleton, J. Steward, and M.A. Richards Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 2011 127 138
9. N.T. Tanner, N.J. Pastis, C. Sherman, G.R. Simon, D. Lewin, and G.A. Silvestri The role of molecular analyses in the era of personalized therapy for advanced NSCLC Lung Cancer 76 2012 131 137
10. T.S. Mok Personalized medicine in lung cancer: what we need to know Nat. Rev. Clin. Oncol. 8 2011 661 668
11. C. Allemani, M. Sant, H.K. Weir, L.C. Richardson, P. Baili, H. Storm, S. Siesling, A. Torrella-Ramos, A.C. Voogd, T. Aareleid, E. Ardanaz, F. Berrino, M. Bielska-Lasota, S. Bolick, C. Cirilli, M. Colonna, P. Contiero, R. Cress, E. Crocetti, J.P. Fulton, P. Grosclaude, T. Hakulinen, M.I. Izarzugaza, P. Malmstrom, K. Peignaux, M. Primic-Zakelj, J. Rachtan, D.C. Safaei, M.J. Sanchez, M.J. Schymura, T. Shen, A. Traina, L. Tryggvadottir, R. Tumino, M. Velten, M. Vercelli, H.J. Wolf, A.S. Woronoff, X. Wu, and M.P. Coleman Breast cancer survival in the US and Europe: a CONCORD high-resolution study Int. J. Cancer 1 2013 1170 1181
12. B.D. Smith, G.L. Smith, A. Hurria, G.N. Hortobagyi, and T.A. Buchholz Future of cancer incidence in the United States: burdens upon an aging, changing nation J. Clin. Oncol. 27 2009 2758 2765
13. M.W. Vannier Screening mammography: what good is it and how can we know if it works? J. Natl. Cancer Inst. 104 2012 1039 1040
14. N. Segnan, S. Rosso, and A. Ponti Is the breast cancer mortality decrease in Sweden due to screening or treatment? Not the right question J. Natl. Cancer Inst. 104 2012 1040 1041
15. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J. Clin. 59 2009 225 249
16. G. Hoff, and J.A. Dominitz Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 59 2010 407 414
17. K. Yamashita, and M. Watanabe Clinical significance of tumor markers and an emerging perspective on colorectal cancer Cancer Sci. 100 2009 195 199
18. H. Tjalsma, A. Bolhuis, J.D. Jongbloed, S. Bron, and J.M. van Dijl Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome Microbiol. Mol. Biol. Rev. 64 2000 515 547
19. M. Gronborg, T.Z. Kristiansen, A. Iwahori, R. Chang, R. Reddy, N. Sato, H. Molina, O.N. Jensen, R.H. Hruban, M.G. Goggins, A. Maitra, and A. Pandey Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol. Cell Proteomics 5 2006 157 171 (Pubitemid 43169348)
20. J.E. Celis, P. Gromov, T. Cabezon, J.M. Moreira, N. Ambartsumian, K. Sandelin, F. Rank, and I. Gromova Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery Mol. Cell Proteomics 3 2004 327 344 (Pubitemid 38702087)
21. M.W. Volmer, Y. Radacz, S.A. Hahn, S. Klein-Scory, K. Stuhler, M. Zapatka, W. Schmiegel, H.E. Meyer, and I. Schwarte-Waldhoff Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: landscaping activity of Smad4 as revealed by a "secretome" analysis Proteomics 4 2004 1324 1334 (Pubitemid 38648020)
22. M.W. Volmer, K. Stuhler, M. Zapatka, A. Schoneck, S. Klein-Scory, W. Schmiegel, H.E. Meyer, and I. Schwarte-Waldhoff Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer Proteomics 5 2005 2587 2601 (Pubitemid 40966486)
23. W. Nickel, and C. Rabouille Mechanisms of regulated unconventional protein secretion Nat. Rev. Mol. Cell Biol. 10 2009 148 155
24. B. Gyorgy, T.G. Szabo, M. Pasztoi, Z. Pal, P. Misjak, B. Aradi, V. Laszlo, E. Pallinger, E. Pap, A. Kittel, G. Nagy, A. Falus, and E.I. Buzas Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles Cell. Mol. Life Sci. 68 2011 2667 2688
25. P. Kharaziha, S. Ceder, Q. Li, and T. Panaretakis Tumor cell-derived exosomes: a message in a bottle Biochim. Biophys. Acta 1826 2012 103 111
26. S. Mathivanan, H. Ji, and R.J. Simpson Exosomes: extracellular organelles important in intercellular communication J. Proteomics 73 2010 1907 1920
27. P. Dowling, and M. Clynes Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers Proteomics 11 2011 794 804
28. J.W. Lim, R.A. Mathias, E.A. Kapp, M.J. Layton, M.C. Faux, A.W. Burgess, H. Ji, and R.J. Simpson Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4 Electrophoresis 33 2012 1873 1880
29. X. Yu, S.L. Harris, and A.J. Levine The regulation of exosome secretion: a novel function of the p53 protein Cancer Res. 66 2006 4795 4801
30. L. Zhong, J. Roybal, R. Chaerkady, W. Zhang, K. Choi, C.A. Alvarez, H. Tran, C.J. Creighton, S. Yan, R.M. Strieter, A. Pandey, and J.M. Kurie Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment Cancer Res. 68 2008 7237 7245
31. L. Cortesi, A. Barchetti, M.E. De, E. Rossi, C.L. Della, L. Marcheselli, G. Tazzioli, M.G. Lazzaretti, G. Ficarra, M. Federico, and A. Iannone Identification of protein clusters predictive of response to chemotherapy in breast cancer patients J. Proteome. Res. 8 2009 4916 4933
32. L. Yao, Y. Zhang, K. Chen, X. Hu, and L.X. Xu Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox PLoS One 6 2011 e24684
33. M.J. Schliekelman, D.L. Gibbons, V.M. Faca, C.J. Creighton, Z.H. Rizvi, Q. Zhang, C.H. Wong, H. Wang, C. Ungewiss, Y.H. Ahn, D.H. Shin, J.M. Kurie, and S.M. Hanash Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer Cancer Res. 71 2011 7670 7682
34. R.J. Fijneman, M. de Wit, M. Pourghiasian, S.R. Piersma, T.V. Pham, M.O. Warmoes, M. Lavaei, C. Piso, F. Smit, P.M. Delis-van Diemen, S.T. van Turenhout, J.S. Terhaar sive Droste, C.J. Mulder, M.A. Blankenstein, E.C. Robanus-Maandag, R. Smits, R. Fodde, V.W. van Hinsbergh, G.A. Meijer, and C.R. Jimenez Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer Clin. Cancer Res. 18 2012 2613 2624
35. C.J. Yu, C.L. Wang, C.I. Wang, C.D. Chen, Y.M. Dan, C.C. Wu, Y.C. Wu, I.N. Lee, Y.H. Tsai, Y.S. Chang, and J.S. Yu Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology J. Proteome. Res. 10 2011 4671 4682
36. K.P. Suijkerbuijk, E. van der Wall, H. Meijrink, X. Pan, I.H. Borel Rinkes, M.G. Ausems, and P.J. van Diest Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer Fam. Cancer 9 2010 321 325
37. M.P. Pavlou, V. Kulasingam, E.R. Sauter, B. Kliethermes, and E.P. Diamandis Nipple aspirate fluid proteome of healthy females and patients with breast cancer Clin. Chem. 56 2010 848 855
38. C.S. Ang, J. Rothacker, H. Patsiouras, A.W. Burgess, and E.C. Nice Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer J. Chromatogr. A 1217 2010 3330 3340
39. C.S. Ang, and E.C. Nice Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces J. Proteome Res. 9 2010 4346 4355
40. C.S. Ang, J. Rothacker, H. Patsiouras, P. Gibbs, A.W. Burgess, and E.C. Nice Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces Electrophoresis 32 2011 1926 1938
41. L.J.W. Bosch, G. Oudgenoeg, A. Hiemstra, S. Mongera, S.R. Piersma, T.V. Pham, N.C.T. van Grieken, J.S. Terhaar Sive Droste, F.A. Oort, S.T. van Turenhout, I. Ben Larbi, C.J.J. Mulder, B. Carvalho, C.R. Jimenez, R.J. Fijneman, and G.A. Meijer Stool Proteomics Reveals New Candidate Biomarkers for Colorectal Cancer Screening 2012
42. C.S. Ang, J. Phung, and E.C. Nice The discovery and validation of colorectal cancer biomarkers Biomed. Chromatogr. 25 2011 82 99
43. T. Oumeraci, B. Schmidt, T. Wolf, M. Zapatka, A. Pich, B. Brors, R. Eils, M. Fleischhacker, B. Schlegelberger, and N.N. von Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology Lung Cancer 72 2011 136 138
44. M. Makridakis, and A. Vlahou Secretome proteomics for discovery of cancer biomarkers J. Proteomics 73 2010 2291 2305
45. S.R. Piersma, U. Fiedler, S. Span, A. Lingnau, T.V. Pham, S. Hoffmann, M.H. Kubbutat, and C.R. Jimenez Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum J. Proteome Res. 9 2010 1913 1922
46. O. Emanuelsson, S. Brunak, H.G. von, and H. Nielsen Locating proteins in the cell using TargetP, SignalP and related tools Nat. Protoc. 2 2007 953 971 (Pubitemid 46745592)
47. Y. Chen, H. Zhang, A. Xu, N. Li, J. Liu, C. Liu, D. Lv, S. Wu, L. Huang, S. Yang, D. He, and X. Xiao Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer Lung Cancer 54 2006 95 102
48. K.H. Chiu, Y.H. Chang, Y.S. Wu, S.H. Lee, and P.C. Liao Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling J. Proteome Res. 10 2011 1110 1125
49. S.H. Shin, J. Kim, S.C. Heo, Y.W. Kwon, Y.M. Kim, I.S. Kim, T.G. Lee, and J.H. Kim Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3 Mol. Cell Proteomics 11 2012 M111
50. J. Chenau, S. Michelland, F. de Fraipont, V. Josserand, J.L. Coll, M.C. Favrot, and M. Seve The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells J. Proteome Res. 8 2009 4579 4591
51. G. Pocsfalvi, G. Votta, V.A. De, I. Fiume, D.A. Raj, G. Marra, M.P. Stoppelli, and I. Iaccarino Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc J. Proteome Res. 10 2011 5326 5337
52. L.J. Huang, S.X. Chen, Y. Huang, W.J. Luo, H.H. Jiang, Q.H. Hu, P.F. Zhang, and H. Yi Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer Lung Cancer 54 2006 87 94
53. X. Lou, T. Xiao, K. Zhao, H. Wang, H. Zheng, D. Lin, Y. Lu, Y. Gao, S. Cheng, S. Liu, and N. Xu Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer J. Proteome Res. 6 2007 1083 1092 (Pubitemid 46480472)
54. C. Planque, V. Kulasingam, C.R. Smith, K. Reckamp, L. Goodglick, and E.P. Diamandis Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell Proteomics 8 2009 2746 2758
55. C.L. Wang, C.I. Wang, P.C. Liao, C.D. Chen, Y. Liang, W.Y. Chuang, Y.H. Tsai, H.C. Chen, Y.S. Chang, J.S. Yu, C.C. Wu, and C.J. Yu Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome J. Proteome Res. 8 2009 4428 4440
56. T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, N. Han, X. Di, M. Li, D. Zhang, K. Su, J. Yuan, H. Zheng, M. Gao, J. He, S. Shi, W. Li, N. Xu, H. Zhang, Y. Liu, K. Zhang, Y. Gao, X. Qian, and S. Cheng An approach to studying lung cancer-related proteins in human blood Mol. Cell Proteomics 4 2005 1480 1486 (Pubitemid 41555474)
57. C.C. Wu, C.W. Hsu, C.D. Chen, C.J. Yu, K.P. Chang, D.I. Tai, H.P. Liu, W.H. Su, Y.S. Chang, and J.S. Yu Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas Mol. Cell Proteomics 9 2010 1100 1117
58. M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson, M. Forsberg, M. Zwahlen, C. Kampf, K. Wester, S. Hober, H. Wernerus, L. Bjorling, and F. Ponten Towards a knowledge-based Human Protein Atlas Nat. Biotechnol. 28 2010 1248 1250
59. C.I. Wang, C.L. Wang, C.W. Wang, C.D. Chen, C.C. Wu, Y. Liang, Y.H. Tsai, Y.S. Chang, J.S. Yu, and C.J. Yu Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome Int. J. Cancer 128 2011 2364 2372
60. J.E. Kim, K.H. Koo, Y.H. Kim, J. Sohn, and Y.G. Park Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model Exp. Mol. Med. 40 2008 709 720
61. S.W. Kim, K. Cheon, C.H. Kim, J.H. Yoon, D.H. Hawke, R. Kobayashi, L. Prudkin, I.I. Wistuba, R. Lotan, W.K. Hong, and J.S. Koo Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method Cancer Res. 67 2007 6565 6573 (Pubitemid 47105500)
62. Y.H. Chang, S.H. Lee, I.C. Liao, S.H. Huang, H.C. Cheng, and P.C. Liao Secretomic analysis identifies A1AT as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells Mol. Cell Proteomics 11 2012 1320 1339
63. D.L. Gibbons, W. Lin, C.J. Creighton, Z.H. Rizvi, P.A. Gregory, G.J. Goodall, N. Thilaganathan, L. Du, Y. Zhang, A. Pertsemlidis, and J.M. Kurie Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression Genes Dev. 23 2009 2140 2151
64. M.P. Bard, J.P. Hegmans, A. Hemmes, T.M. Luider, R. Willemsen, L.A. Severijnen, J.P. van Meerbeeck, S.A. Burgers, H.C. Hoogsteden, and B.N. Lambrecht Proteomic analysis of exosomes isolated from human malignant pleural effusions Am. J. Respir. Cell Mol. Biol. 31 2004 114 121 (Pubitemid 38888047)
65. Y.C. Tyan, H.Y. Wu, W.W. Lai, W.C. Su, and P.C. Liao Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry J. Proteome Res. 4 2005 1274 1286
66. Y.C. Tyan, H.Y. Wu, W.C. Su, P.W. Chen, and P.C. Liao Proteomic analysis of human pleural effusion Proteomics 5 2005 1062 1074
67. W.Y. Hsieh, M.W. Chen, H.T. Ho, T.M. You, and Y.T. Lu Identification of differentially expressed proteins in human malignant pleural effusions Eur. Respir. J. 28 2006 1178 1185
68. M. Pernemalm, P.L. De, H. Eriksson, E. Branden, H. Koyi, L. Kanter, R. Lewensohn, and J. Lehtio Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion Proteomics 9 2009 3414 3424
69. A.M. Rodriguez-Pineiro, S. Blanco-Prieto, N. Sanchez-Otero, F.J. Rodriguez-Berrocal, and M.P. de la Cadena On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion J. Proteomics 73 2010 1511 1522
70. A. Soltermann, R. Ossola, S. Kilgus-Hawelski, E.A. von, T. Suter, R. Aebersold, and H. Moch N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics Cancer 114 2008 124 133 (Pubitemid 351640792)
71. Z. Wang, C. Wang, X. Huang, Y. Shen, J. Shen, and K. Ying Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients Biochim. Biophys. Acta 1824 2012 692 700
72. F. Mbeunkui, B.J. Metge, L.A. Shevde, and L.K. Pannell Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer J. Proteome Res. 6 2007 2993 3002 (Pubitemid 47310184)
73. T.C. Lai, H.C. Chou, Y.W. Chen, T.R. Lee, H.T. Chan, H.H. Shen, W.T. Lee, S.T. Lin, Y.C. Lu, C.L. Wu, and H.L. Chan Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis J. Proteome Res. 9 2010 1302 1322
74. X. Liang, J. Huuskonen, M. Hajivandi, R. Manzanedo, P. Predki, J.R. Amshey, and R.M. Pope Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines Proteomics 9 2009 182 193
75. J.W. Chang, U.B. Kang, D.H. Kim, J.K. Yi, J.W. Lee, D.Y. Noh, C. Lee, and M.H. Yu Identification of circulating endorepellin LG3 fragment: potential use as a serological biomarker for breast cancer Proteomics Clin. Appl. 2 2008 23 32 (Pubitemid 351210913)
76. Y. Ahn, U.B. Kang, J. Kim, and C. Lee Mining of serum glycoproteins by an indirect approach using cell line secretome Mol. Cell 29 2010 123 130
77. F. Chevalier, J. Depagne, S. Hem, S. Chevillard, J. Bensimon, P. Bertrand, and J. Lebeau Accumulation of cyclophilin A isoforms in conditioned medium of irradiated breast cancer cells Proteomics 12 2012 1756 1766
78. B.J. Xu, W. Yan, B. Jovanovic, A.Q. An, N. Cheng, M.E. Aakre, Y. Yi, J. Eng, A.J. Link, and H.L. Moses Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts Proteomics 10 2010 2458 2470
79. A. Bronisz, J. Godlewski, J.A. Wallace, A.S. Merchant, M.O. Nowicki, H. Mathsyaraja, R. Srinivasan, A.J. Trimboli, C.K. Martin, F. Li, L. Yu, S.A. Fernandez, T. Pecot, T.J. Rosol, S. Cory, M. Hallett, M. Park, M.G. Piper, C.B. Marsh, L.D. Yee, R.E. Jimenez, G. Nuovo, S.E. Lawler, E.A. Chiocca, G. Leone, and M.C. Ostrowski Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 Nat. Cell Biol. 14 2012 159 167
80. R.A. Toillon, C. Lagadec, A. Page, V. Chopin, P.E. Sautiere, J.M. Ricort, J. Lemoine, M. Zhang, H. Hondermarck, and X. Le Bourhis Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin Mol. Cell Proteomics 6 2007 1239 1247 (Pubitemid 47099232)
81. J.M. Jacobs, K.M. Waters, L.E. Kathmann, D.G. Camp, H.S. Wiley, R.D. Smith, and B.D. Thrall The mammary epithelial cell secretome and its regulation by signal transduction pathways J. Proteome Res. 7 2008 558 569 (Pubitemid 351294018)
82. G.K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, and D. Bull Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study BMJ 335 2007 1134
83. C.N. Perera, H.S. Spalding, S.I. Mohammed, and I.G. Camarillo Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach Exp. Biol. Med. (Maywood) 233 2008 708 720
84. G.S. Butler, R.A. Dean, E.M. Tam, and C.M. Overall Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding Mol. Cell. Biol. 28 2008 4896 4914
85. P.A. Konstantinopoulos, M.V. Karamouzis, A.G. Papatsoris, and A.G. Papavassiliou Matrix metalloproteinase inhibitors as anticancer agents Int. J. Biochem. Cell Biol. 40 2008 1156 1168
86. J.E. Celis, J.M. Moreira, T. Cabezon, P. Gromov, E. Friis, F. Rank, and I. Gromova Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions Mol. Cell Proteomics 4 2005 492 522 (Pubitemid 40590568)
87. P. Gromov, I. Gromova, J. Bunkenborg, T. Cabezon, J.M. Moreira, V. Timmermans-Wielenga, P. Roepstorff, F. Rank, and J.E. Celis Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast Mol. Oncol. 4 2010 65 89
88. C. Raso, C. Cosentino, M. Gaspari, N. Malara, X. Han, D. McClatchy, S.K. Park, M. Renne, N. Vadala, U. Prati, G. Cuda, V. Mollace, F. Amato, and J.R. Yates III Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis J. Proteome Res. 11 2012 3199 3210
89. T.M. Pawlik, D.H. Hawke, Y. Liu, S. Krishnamurthy, H. Fritsche, K.K. Hunt, and H.M. Kuerer Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein BMC Cancer 6 2006 68
90. H. Xue, B. Lu, J. Zhang, M. Wu, Q. Huang, Q. Wu, H. Sheng, D. Wu, J. Hu, and M. Lai Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach J. Proteome Res. 9 2010 545 555
91. C.C. Wu, H.C. Chen, S.J. Chen, H.P. Liu, Y.Y. Hsieh, C.J. Yu, R. Tang, L.L. Hsieh, J.S. Yu, and Y.S. Chang Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 8 2008 316 332 (Pubitemid 351212330)
92. G.S. Karagiannis, C. Petraki, I. Prassas, P. Saraon, N. Musrap, A. Dimitromanolakis, and E.P. Diamandis Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis Oncotarget 3 2012 267 285
93. S. Mathivanan, H. Ji, B.J. Tauro, Y.S. Chen, and R.J. Simpson Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry J. Proteomics 5 2012 141 149
94. D.S. Choi, J.M. Lee, G.W. Park, H.W. Lim, J.Y. Bang, Y.K. Kim, K.H. Kwon, H.J. Kwon, K.P. Kim, and Y.S. Gho Proteomic analysis of microvesicles derived from human colorectal cancer cells J. Proteome Res. 6 2007 4646 4655
95. S. Mathivanan, J.W. Lim, B.J. Tauro, H. Ji, R.L. Moritz, and R.J. Simpson Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature Mol. Cell Proteomics 9 2010 197 208
96. B.J. Tauro, D.W. Greening, R.A. Mathias, H. Ji, S. Mathivanan, A.M. Scott, and R.J. Simpson Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes Methods 56 2012 293 304
97. D.S. Choi, J.O. Park, S.C. Jang, Y.J. Yoon, J.W. Jung, D.Y. Choi, J.W. Kim, J.S. Kang, J. Park, D. Hwang, K.H. Lee, S.H. Park, Y.K. Kim, D.M. Desiderio, K.P. Kim, and Y.S. Gho Proteomic analysis of microvesicles derived from human colorectal cancer ascites Proteomics 11 2011 2745 2751
98. H.J. Shi, R. Stubbs, and K. Hood Characterization of de novo synthesized proteins released from human colorectal tumour explants Electrophoresis 30 2009 2442 2453
99. R.J. Davies, A. Freeman, L.S. Morris, S. Bingham, S. Dilworth, I. Scott, R.A. Laskey, R. Miller, and N. Coleman Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool Lancet 359 2002 1917 1919 (Pubitemid 34615772)
100. M. Demory Beckler, J.N. Higginbotham, J.L. Franklin, A.J. Ham, P.J. Halvey, I.E. Imasuen, C. Whitwell, M. Li, D.C. Liebler, and R.J. Coffey Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS Mol. Cell Proteomics 12 2013 343 355
101. T. Hata, K. Murakami, H. Nakatani, Y. Yamamoto, T. Matsuda, and N. Aoki Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs Biochem. Biophys. Res. Commun. 396 2010 528 533
102. J. Tan, W.J. Zhao, J.K. Yu, S. Ma, M.J. Sailor, and J.M. Wu Capture, enrichment, and mass spectrometric detection of low-molecular-weight biomarkers with nanoporous silicon microparticles Adv. Healthc. Mater. 1 2012 742 750
103. L.C. Gillet, P. Navarro, S. Tate, H. Rost, N. Selevsek, L. Reiter, R. Bonner, and R. Aebersold Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis Mol. Cell Proteomics 11 2012 O111
104. P. Picotti, and R. Aebersold Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions Nat. Methods 9 2012 555 566
105. S.D. Sherrod, M.V. Myers, M. Li, J.S. Myers, K.L. Carpenter, B. Maclean, M.J. Maccoss, D.C. Liebler, and A.J. Ham Label-free quantitation of protein modifications by pseudo selected reaction monitoring with internal reference peptides J. Proteome Res. 11 2012 3467 3479
106. S. Sahoo, E. Klychko, T. Thorne, S. Misener, K.M. Schultz, M. Millay, A. Ito, T. Liu, C. Kamide, H. Agrawal, H. Perlman, G. Qin, R. Kishore, and D.W. Losordo Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity Circ. Res. 109 2011 724 728
107. X. Luo, Y. Liu, R. Wang, H. Hu, R. Zeng, and H. Chen A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer J. Proteomics 74 2011 528 538
108. H. Xiao, L. Zhang, H. Zhou, J.M. Lee, E.B. Garon, and D.T. Wong Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry Mol. Cell Proteomics 11 2012 M111
109. V. Kulasingam, and E.P. Diamandis Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets Mol. Cell Proteomics 6 2007 1997 2011 (Pubitemid 350201873)
110. S.A. Whelan, J. He, M. Lu, P. Souda, R. Saxton, K.F. Faull, J.P. Whitelegge, and H. Chang Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid J. Proteome Res. 11 2012 5034 5045
111. S.M. Varnum, C.C. Covington, R.L. Woodbury, K. Petritis, L.J. Kangas, M.S. Abdullah, J.G. Pounds, R.D. Smith, and R.C. Zangar Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer Breast Cancer Res. Treat. 80 2003 87 97 (Pubitemid 36851288)
112. H. Alexander, A.L. Stegner, C. Wagner-Mann, G.C.Du. Bois, S. Alexander, and E.R. Sauter Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid Clin. Cancer Res. 10 2004 7500 7510 (Pubitemid 39557511)
113. L. Yao, W. Lao, Y. Zhang, X. Tang, X. Hu, C. He, X. Hu, and L.X. Xu Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues J. Proteome Res. 11 2012 3281 3294